Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models. Founded by C. Geoffrey Davis, Jeffrey Port, John Klacking, and Shahin Rafii in 2012, Angiocrine Bioscience is headquartered in New York.
FOUNDED:
2012
INDUSTRY:
Biotechnology, Health Diagnostics, Therapeutics
FOUNDERS:
C. Geoffrey Davis, Jeffrey Port, John Klacking, Shahin Rafii
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
